{"entity":{"type":"insider","cik":"0001318485","url":"/insider/0001318485","json_url":"/insider/0001318485.json","name":"SOLAND DANIEL B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":11,"first":"2007-08-17","last":"2023-08-03","span_basis":"filed_date"},"name_variants":[{"name":"SOLAND DANIEL B","source":"filing","n_filings":11,"first_seen":"2007-08-17","last_seen":"2023-08-03"}],"transactions":[{"id":8043661,"accession":"0001209191-23-044458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-044458","line_url":"/filing/0001209191-23-044458#line-1","is_derivative":false,"issuer_cik":"0001318485","issuer_name":"DBV Technologies S.A.","issuer_ticker":"DBVT","issuer_name_source":null,"issuer_url":"/issuer/0001318485","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":24300.0,"total_display":"24,300.00","total_whole":"24,300","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":4862450,"accession":"0001415889-21-003112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003112","line_url":"/filing/0001415889-21-003112#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":59500.0,"total_display":"59,500.00","total_whole":"59,500","shares_owned_after":78843.0,"shares_owned_after_display":"78,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"},{"id":4501119,"accession":"0001415889-21-001353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-001353","line_url":"/filing/0001415889-21-001353#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.895,"price_display":"3.90","price_state":"stated","total_value":38950.0,"total_display":"38,950.00","total_whole":"38,950","shares_owned_after":28843.0,"shares_owned_after_display":"28,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-05","scope":"insider"},{"id":8631520,"accession":"0001567619-19-018888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-018888","line_url":"/filing/0001567619-19-018888#line-2","is_derivative":false,"issuer_cik":"0001318485","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001318485","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7962.0,"shares_display":"7,962","price_per_share":11.8686,"price_display":"11.87","price_state":"stated","total_value":94497.7932,"total_display":"94,497.79","total_whole":"94,498","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-27","filed_date":"2019-09-30","scope":"insider"},{"id":8631516,"accession":"0001567619-19-018888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-018888","line_url":"/filing/0001567619-19-018888#line-1","is_derivative":false,"issuer_cik":"0001318485","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001318485","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2038.0,"shares_display":"2,038","price_per_share":11.9,"price_display":"11.90","price_state":"stated","total_value":24252.2,"total_display":"24,252.20","total_whole":"24,252","shares_owned_after":2038.0,"shares_owned_after_display":"2,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-26","filed_date":"2019-09-30","scope":"insider"},{"id":6737021,"accession":"0001415889-18-000338","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-18-000338","line_url":"/filing/0001415889-18-000338#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":22.52,"price_display":"22.52","price_state":"stated","total_value":67560.0,"total_display":"67,560.00","total_whole":"67,560","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-02","filed_date":"2018-03-02","scope":"insider"},{"id":6737019,"accession":"0001415889-18-000338","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-18-000338","line_url":"/filing/0001415889-18-000338","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":23.90714285714286,"price_display":"23.91","price_state":"stated","total_value":167350.0,"total_display":"167,350.00","total_whole":"167,350","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-02","scope":"insider","n_lines":3},{"id":2891534,"accession":"0001127602-12-009701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-12-009701","line_url":"/filing/0001127602-12-009701#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":32.99,"price_display":"32.99","price_state":"stated","total_value":989700.0,"total_display":"989,700.00","total_whole":"989,700","shares_owned_after":42881.0,"shares_owned_after_display":"42,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-06","scope":"insider"},{"id":7666589,"accession":"0001181431-10-025198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-025198","line_url":"/filing/0001181431-10-025198#line-2","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Operating Officer","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":11.91,"price_display":"11.91","price_state":"stated","total_value":119100.0,"total_display":"119,100.00","total_whole":"119,100","shares_owned_after":93638.0,"shares_owned_after_display":"93,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-07","filed_date":"2010-05-07","scope":"insider"},{"id":7666587,"accession":"0001181431-10-025198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-025198","line_url":"/filing/0001181431-10-025198#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Operating Officer","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":12.5203,"price_display":"12.52","price_state":"stated","total_value":125203.0,"total_display":"125,203.00","total_whole":"125,203","shares_owned_after":83638.0,"shares_owned_after_display":"83,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-06","filed_date":"2010-05-07","scope":"insider"},{"id":5920220,"accession":"0001181431-09-015476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-015476","line_url":"/filing/0001181431-09-015476#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":121500.0,"total_display":"121,500.00","total_whole":"121,500","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-12","filed_date":"2009-03-13","scope":"insider"},{"id":7225159,"accession":"0001181431-07-067816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-067816","line_url":"/filing/0001181431-07-067816#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.26,"price_display":"7.26","price_state":"stated","total_value":72600.0,"total_display":"72,600.00","total_whole":"72,600","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-07","filed_date":"2007-11-09","scope":"insider"},{"id":6838403,"accession":"0001181431-07-066142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-066142","line_url":"/filing/0001181431-07-066142#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":8.31,"price_display":"8.31","price_state":"stated","total_value":124650.0,"total_display":"124,650.00","total_whole":"124,650","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-01","filed_date":"2007-11-05","scope":"insider"},{"id":7174079,"accession":"0000898430-07-003281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000898430-07-003281","line_url":"/filing/0000898430-07-003281#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001318485","owner_name":"SOLAND DANIEL B","owner_display_name":"SOLAND DANIEL B","owner_url":"/insider/0001318485","role":"Officer (VP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","total_whole":"120,000","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-16","filed_date":"2007-08-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001613780","name":"DBV Technologies S.A.","url":"/issuer/0001613780","role":"Director","n_filings":1,"first_seen":"2023-08-03","last_seen":"2023-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Officer (CHIEF OPERATING OFFICER)","n_filings":2,"first_seen":"2021-03-05","last_seen":"2021-06-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Director","n_filings":1,"first_seen":"2019-09-30","last_seen":"2019-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Director","n_filings":1,"first_seen":"2018-03-02","last_seen":"2018-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Officer (VP, Chief Operating Officer)","n_filings":6,"first_seen":"2007-08-17","last_seen":"2012-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001318485","retrieved_at":"2026-08-24T14:10:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}